undefined

Andrew Hammond

Co-founder and head of R&D at Biocentis, an Imperial College London spin-out founded in 2022. Has a background in molecular biology and experience advancing gene editing technology for use in insects.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app